Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C

Association of Lipid Profiles With Hepatitis C Viral Load in Chronic Hepatitis C Patients With Genotype 1 or 2 Infection

(2009) Ching-Sheng Hsu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development

(2009) Leen Delang et al.   HEPATOLOGY

Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection

(2009) Andreas Mas Marques et al.   INFECTION GENETICS AND EVOLUTION

An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads

(2009) Hitomi Sezaki et al.   INTERVIROLOGY

Does fluvastatin favour HCV replicationin vivo? A pilot study on HIV-HCV coinfected patients

(2009) L. Milazzo et al.   JOURNAL OF VIRAL HEPATITIS

Fluvastatin Inhibits Hepatitis C Replication in Humans

(2008) Ted Bader et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: A community-based study

(2008) Chia-Yen Dai et al.   JOURNAL OF HEPATOLOGY